These results, as well as additional experiments comparing the efficiency of different Cre drivers (Extended Data Fig. 4 and Supplementary Note 2), lead us to conclude that ERG+ cancers preferentially initiate in Nkx3.1+ BasalLum cells. The gene discussed is ERG; the disease is cancer.